Source: Apricus Biosciences Inc. Date: August 25 2011 09:00 ET Apricus Biosciences to Present Corporate Overview at the 2011 Southern California Investor Conference SAN DIEGO Aug. 25 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) an ...

guest published in:09-05   reply:0   view:23    last updated:09-05 06:29( guest )

Las Vegas NV Aug. 25 2011 (GreatStocks.info) -- http://www.globenewswire.com/newsroom/prs/?pkgid=10311 CPAlead a premier online marketing company that specializes in digital content monetization today announced... Read more » CHICAGO Aug. 25 2011 (GreatStocks.info) -- LKQ Corporation (Na ...

guest published in:08-26   reply:0   view:31    last updated:08-26 05:29( guest )

It is also seeking guidance from regulatory agencies for Femprox its product for the treatment of female sexual arousal disorder in Europe and Canada. For additional background on the Company's NexACT drug ...

guest published in:07-02   reply:0   view:25    last updated:07-02 13:29( guest )

Philadelphia Penn.:Boldly claiming cures for all approach to ailments posters have extended been a favored type of marketing for manufacturers pharmacies and quack medical doctors alike. vibrant colours and punchy slogans captured the publics attention making utilization of humor satire and ca ...

guest published in:04-27   reply:0   view:40    last updated:04-27 21:33( guest )

author:admin    comment:0   view:3   userful 1

WOODCLIFF LAKE N.J. May 17 2012 /PRNewswire/ -- Eisai announced today that 15 abstracts highlighting new study results will be presented during the 48 th Annual Meeting of the American Society of Clinical ...

author:admin    comment:0   view:4   userful 1

ANN ARBOR Mich. -- Aastrom Biosciences Inc. the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases today announced that ...

author:admin    comment:0   view:8   userful 1

Gilead Sciences Inc. today announced that 30 abstracts examining the company s products and investigational agents for hepatitis B and C have been selected for presentation at the 47th Annual Meeting of the European Association for the Study of the Liver taking place April 18-22 in Barcelona Spain.

author:admin    comment:0   view:9   userful 1

TORONTO -- GeneNews Limited a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management announced that an abstract entitled "Blood ...

author:admin    comment:0   view:10   userful 1

Galectin Therapeutics the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer today announced that it will present at Digestive Disease Week May 19-22 2012 in San Diego CA.